New Zealand Pharmaceuticals & Biotech Most Popular Stocks

AFT Pharmaceuticals

Market Cap: NZ$372.3m

Develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally.

Pacific Edge

Market Cap: NZ$179.0m

A cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients.

BLIS Technologies

Market Cap: NZ$20.5m

Develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity in New Zealand, Asia Pacific, Europe Middle East and Africa, and North America.

Rua Bioscience

Market Cap: NZ$10.5m

Engages in the research, development, and sale of pharmaceutical products in New Zealand and internationally.